LAURA MCLAUGHLIN: Open Payments
NPI 1972871416 · CEDAR RAPIDS, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$506 in 30 payments from 11 companies in 2025. Trend: 2023 $488 · 2024 $507 · 2025 $506
Food & beverage: $506
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $161 |
| PFIZER INC. | 4 | $69 |
| Amgen Inc. | 3 | $50 |
| AstraZeneca Pharmaceuticals LP | 3 | $50 |
| Kowa Pharmaceuticals America, Inc. | 3 | $49 |
| Exact Sciences Corporation | 2 | $31 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $28 |
| Phathom Pharmaceuticals, Inc. | 1 | $22 |
| Axsome Therapeutics, Inc. | 1 | $18 |
| Dexcom, Inc. | 1 | $16 |
Products named: VRAYLAR, NURTEC ODT, QULIPTA, ZORYVE, OTEZLA, CAPLYTA, VOQUEZNA, AIRSUPRA.
Industry payments across IA — which companies pay providers there.
